New research

Baby aspirin may reduce breast cancer risk, study says

(REUTERS/Eric Gaillard)

A new study published in Breast Cancer Research suggests that regularly taking low-dose aspirin can lower one’s risk of developing breast cancer.

The Washington Post reports researchers surveyed 57,164 women who were, for the most part, in their 60s. About 23 percent took a low-dose aspirin (81 milligrams), 11 percent took full-dose aspirin (325 milligrams), 18 percent opted for ibuprofen, and 10 percent took other types of nonsteroidal anti-inflammatory drugs (NSAID). All of the participants took their chosen medication at least three times per week.

During a seven-year period, 1,457 women were diagnosed with breast-cancer. But women who regularly took a low-dose aspirin were 16 percent less likely to develop the disease than women who took no NSAID. And they were 20 percent less likely to develop the most prevalent type of breast cancer, which is hormone-receptor-positive and HER2-negative.

Researchers could not link any of the other medications to a similar reduction in breast cancer risk.

The results of the study should be met with some trepidation. Hormone therapy and alcohol consumption — both thought to be breast cancer risks — were more common among the study participants than normal, for one thing. All of the study participants were white, for another. But the new research suggests that taking a common medication, which many people already ingest to prevent cardiovascular disease, can reduce the risks of another devastating disease.

Read the full story at The Washington Post.


Mexican teen wins entrepreneurial award for bra that can detect the earliest stages of breast cancer

Sleep disturbance could affect breast cancer risk, study finds

Holy grail of cancer research could change lives of women at risk of breast cancer

Leave a Reply

Your email address will not be published. Required fields are marked *